Lineus Medical® Signs Global Veterinary Distribution Partner
eMusic Wire/10228884

FAYETTEVILLE, Ark. - eMusicWire -- Lineus Medical continues to expand its distribution network for SafeBreak® Vascular. This time, it's in the veterinary space, with SafeBreak® Vascular Vet. Lineus has signed an exclusive, global, private-label agreement with a global, animal-health technology and services company dedicated to supporting the companion, equine, and large-animal veterinary markets. The global distribution partner has a presence in 19 countries servicing over 100,000 customers worldwide positioning them to deliver exceptional care to their patients when and where it is needed.

SafeBreak Vascular Vet is a first of its kind breakaway device designed to remove harmful forces from peripheral IV lines by intentionally separating when damaging levels of force are applied to the IV line. By preventing harmful IV line forces from reaching the animal's catheter, SafeBreak Vascular Vet reduces IV complications requiring an IV restart. 1,2 When SafeBreak separates, a new, sterile SafeBreak can be placed in the line, and the animal's infusion restarted without the need for additional needlesticks, wasted supplies and wasted time for the veterinary practice.

More on eMusic Wire

• Wave2 Launches New Dynamic Data Integration Features to Elevate Bank and Credit Union Convenience
• Texas Advocacy Project Aids 10k+ Abuse Victims Annually; Offers Subject Matter Experts for Domestic Violence Awareness Month
• Introducing Stack & Sprout: The Revolutionary Vertical Plant Growing System for Urban Gardeners
• Higi Selects ThoroughCare to Assist in Managing Chronically Ill Patients
• Introducing the State-of-the-Art National Security Operations Center: Enhancing Safety and Vigilance Nationwide

A randomized controlled trial with 367 dogs was published in the Journal of American Veterinary Medical Association (JAVMA) and completed at Colorado State University in 2022. The results of this study concluded that SafeBreak significantly reduced IV complications by 65%.1

Vance Clement, CEO of Lineus Medical, said, "The partnership with this large global distributor is an incredible step forward in our efforts to make SafeBreak the standard in IV care for both human and animal patients. We are proud to be working with a global, veterinary medical product distributor, and we believe that this partnership will bring SafeBreak's break-away technology to the veterinary space much faster than we could have accomplished on our own."

ABOUT LINEUS MEDICAL
Lineus Medical is the developer of vascular access products that are designed to improve the patient experience, make healthcare workers' jobs easier and lower the overall cost of healthcare. Learn more at www.lineusmed.com and follow us on LinkedIn or Twitter.

1. Colorado State University Study Data on File
2. University of Tennessee Large Animal Study Data on File

MKG-0190 REV 00